These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects. Hatz C; von Sonnenburg F; Casula D; Lattanzi M; Leroux-Roels G Vaccine; 2012 May; 30(23):3470-7. PubMed ID: 22446638 [TBL] [Abstract][Full Text] [Related]
24. Update on influenza A (H1N1) 2009 monovalent vaccines. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398 [TBL] [Abstract][Full Text] [Related]
25. Factors associated with uptake of seasonal and pandemic influenza vaccine among clinical risk groups in the UK: an analysis using the General Practice Research Database. Sammon CJ; McGrogan A; Snowball J; de Vries CS Vaccine; 2012 Mar; 30(14):2483-9. PubMed ID: 22133511 [TBL] [Abstract][Full Text] [Related]
28. Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice. Prescrire Int; 2013 Sep; 22(141):201-4. PubMed ID: 24171209 [TBL] [Abstract][Full Text] [Related]
29. Results obtained with the NIVGRIP inactivated influenza vaccine applicable by nasal and/or oral route. Petrescu AL; Cajal N Virologie; 1984; 35(4):307-14. PubMed ID: 6516213 [TBL] [Abstract][Full Text] [Related]
30. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic. Engelhard D; Zakay-Rones Z; Shapira MY; Resnick I; Averbuch D; Grisariu S; Dray L; Djian E; Strauss-Liviatan N; Grotto I; Wolf DG; Or R Vaccine; 2011 Feb; 29(9):1777-82. PubMed ID: 21216315 [TBL] [Abstract][Full Text] [Related]
31. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Davis MM; Taubert K; Benin AL; Brown DW; Mensah GA; Baddour LM; Dunbar S; Krumholz HM; ; ; ; ; ; ; ; ; ; ; J Am Coll Cardiol; 2006 Oct; 48(7):1498-502. PubMed ID: 17010820 [TBL] [Abstract][Full Text] [Related]
32. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy. Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995 [TBL] [Abstract][Full Text] [Related]
33. Live attenuated versus inactivated influenza vaccine in infants and young children. Belshe RB; Edwards KM; Vesikari T; Black SV; Walker RE; Hultquist M; Kemble G; Connor EM; N Engl J Med; 2007 Feb; 356(7):685-96. PubMed ID: 17301299 [TBL] [Abstract][Full Text] [Related]
34. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. Vesikari T; Pellegrini M; Karvonen A; Groth N; Borkowski A; O'Hagan DT; Podda A Pediatr Infect Dis J; 2009 Jul; 28(7):563-71. PubMed ID: 19561422 [TBL] [Abstract][Full Text] [Related]
35. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine. Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864 [TBL] [Abstract][Full Text] [Related]
36. Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine. Tambyah PA; Wilder-Smith A; Pavlova BG; Barrett PN; Oh HM; Hui DS; Yuen KY; Fritsch S; Aichinger G; Loew-Baselli A; van der Velden M; Maritsch F; Kistner O; Ehrlich HJ Vaccine; 2012 Jan; 30(2):329-35. PubMed ID: 22080174 [TBL] [Abstract][Full Text] [Related]
37. Influenza vaccination in Turkey: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate. Ciblak MA; Vaccine; 2013 Jan; 31(3):518-23. PubMed ID: 23174194 [TBL] [Abstract][Full Text] [Related]
38. Epidemiological studies on influenza in familial and general population groups. I. Preliminary report on studies with adjuvant vaccines. PHILIP RN; BELL JA; DAVIS DJ; BEEM MO; BEIGELMAN PM Am J Public Health Nations Health; 1954 Jan; 44(1):34-42. PubMed ID: 13114482 [No Abstract] [Full Text] [Related]
39. [Evaluation of the efficacy of mass vaccinations against influenza. 3]. Bobyleva TK; Slepushkin AN; Russina AE; Vitkina BS; Grineberg IR Zh Mikrobiol Epidemiol Immunobiol; 1971 Sep; 48():18-23. PubMed ID: 4255868 [No Abstract] [Full Text] [Related]